Page 3 - Most Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ResearchAndMarkets.com s offering. CAR-T cell therapy is a remarkably promising treatment for cancer patients. It is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the power to easily recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as living drugs. T-cells form the backbone of CAR-T cell therapy. T-cells are the workhorses of our immune system and play a key role in directing the immune response and killing cells infected by pathogens. In CAR-T cell therapy, blood is drawn from the patient and the T-cells are separated out. In the laboratory, a disarmed virus is then used to genetically engineer the T-cells to produce chimeric antigen receptors (CARs) on their surface. These receptors are synthetic and do not exist naturally. Once infused into the patient, these CARs enable the T-cells to recognize and get attached to an a

Astellas adaptimmuneAllogene maxcyteJuno oxford biomedicaKymriah tisagenlecleucelAttars biotherapeuticsCellectis servierOxford biomedicaTecartus brexucabtageneYescarta axicabtageneAleta biotherapeuticsAstellas xyphosLaura woodJanssen biotech incCelgene corporationPromab biotechnologies incFormula pharmaceuticals inc